Thu, June 27, 2024
Wed, June 26, 2024
Tue, June 25, 2024
Mon, June 24, 2024
Fri, June 21, 2024

Francois Brisebois Initiated (ADVM) at Buy and Held Target at $25 on, Jun 25th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-25-on-jun-25th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Francois Brisebois of Oppenheimer, Initiated "Adverum Biotechnologies, Inc." (ADVM) at Buy and Held Target at $25 on, Jun 25th, 2024.

Francois has made no other calls on ADVM in the last 4 months.



There are 5 other peers that have a rating on ADVM. Out of the 5 peers that are also analyzing ADVM, 1 agrees with Francois's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Luca Issi of "RBC Capital" Maintained at Hold with Decreased Target to $20 on, Tuesday, March 19th, 2024


These are the ratings of the 4 analyists that currently disagree with Francois


  • Joon Lee of "Truist Securities" Maintained at Strong Buy and Held Target at $60 on, Wednesday, May 15th, 2024
  • Matthew Caufield of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $30 on, Friday, May 10th, 2024
  • Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Decreased Target to $22 on, Monday, April 29th, 2024
  • Daniil Gataulin of "Chardan Capital" Reiterated at Strong Buy with Increased Target to $40 on, Tuesday, March 19th, 2024

Publication Contributing Sources